Wouter H. van Geffen

1.4k total citations
43 papers, 687 citations indexed

About

Wouter H. van Geffen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biomedical Engineering. According to data from OpenAlex, Wouter H. van Geffen has authored 43 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 7 papers in Biomedical Engineering. Recurrent topics in Wouter H. van Geffen's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Lung Cancer Treatments and Mutations (13 papers) and Respiratory Support and Mechanisms (12 papers). Wouter H. van Geffen is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Lung Cancer Treatments and Mutations (13 papers) and Respiratory Support and Mechanisms (12 papers). Wouter H. van Geffen collaborates with scholars based in Netherlands, United Kingdom and Italy. Wouter H. van Geffen's co-authors include Huib A.M. Kerstjens, Dirk‐Jan Slebos, Pallav L. Shah, Felix Herth, Wim Timens, Gaëtan Deslée, Lizza Hendriks, Dirkje S. Postma, Machteld N. Hylkema and Marie Geerlings and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and CHEST Journal.

In The Last Decade

Wouter H. van Geffen

40 papers receiving 681 citations

Peers

Countries citing papers authored by Wouter H. van Geffen

Since Specialization

Citations

This map shows the geographic impact of Wouter H. van Geffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter H. van Geffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter H. van Geffen more than expected).

Fields of papers citing papers by Wouter H. van Geffen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter H. van Geffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter H. van Geffen. The network helps show where Wouter H. van Geffen may publish in the future.

Co-authorship network of co-authors of Wouter H. van Geffen

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter H. van Geffen. A scholar is included among the top collaborators of Wouter H. van Geffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter H. van Geffen. Wouter H. van Geffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The current state of ultrasound training in pulmonary residency programmes in the Netherlands: an educational review 2025 ·Breathe ·(unknown), (unknown), (unknown), Wouter H. van Geffen, Mireille A. Edens, Jos A. Stigt, Dirk‐Jan Slebos, Marieke L. Duiverman	1
2	Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastases 2025 ·Lung Cancer ·(unknown), Anna Sadowska, Juliette Degens, (unknown), Frederike Bensch, (unknown), (unknown), Wouter H. van Geffen, (unknown), (unknown), Cordula Pitz, Dirk K.M. De Ruysscher, Lizza Hendriks	0
3	The electronic nose in lung cancer diagnostics: a systematic review and meta-analysis 2024 ·ERJ Open Research ·(unknown), (unknown), (unknown), (unknown), Nic J.G.M. Veeger, Michel M. van den Heuvel, Wouter H. van Geffen	0
4	ERS International Congress 2022: highlights from the Thoracic Oncology Assembly 2023 ·ERJ Open Research ·(unknown), Wouter H. van Geffen, (unknown), (unknown), (unknown), (unknown), Lucía Viola, (unknown), Georgia Hardavella	1
5	Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study 2023 ·The Lancet Regional Health - Europe ·(unknown), Ronald Damhuis, Anthonie J. van der Wekken, Lizza Hendriks, Harry J.M. Groen, Wouter H. van Geffen	24
6	P1.28-08 Definition of Resectable Stage III Non-Small Cell Lung Cancer: A Systematic Review from EORTC Lung Cancer Group 2023 ·Journal of Thoracic Oncology ·(unknown), (unknown), Valérie Durieux, Wouter H. van Geffen, (unknown), (unknown), Hugo Arasanz, Elena Prisciandaro, Roberto Ferrara, Jules L. Derks, Jan H. von der Thüsen, Chris Dickhoff, Mariana Brandão, Corinne Faivre‐Finn, John Edwards, Dirk De Ruysscher, Jordi Remón, Anne‐Marie C. Dingemans, Thierry Berghmans	2
7	Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands 2023 ·JTO Clinical and Research Reports ·(unknown), (unknown), Ronald Damhuis, Lizza Hendriks, Peter W.A. Kunst, Mieke J. Aarts, Wouter H. van Geffen	5
8	Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors 2023 ·Lung Cancer ·(unknown), (unknown), Ronald Damhuis, Peter W.A. Kunst, Dirk K.M. De Ruysscher, Lizza Hendriks, Wouter H. van Geffen, Mieke J. Aarts	3
9	High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study 2022 ·PLoS ONE ·(unknown), Nic J.G.M. Veeger, (unknown), Marieke L. Duiverman, Wouter H. van Geffen	9
10	Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy 2021 ·Lung Cancer ·(unknown), Ronald Damhuis, Lizza Hendriks, Adrianus J. de Langen, Wim Timens, Ben J.W. Venmans, Wouter H. van Geffen	32
11	The electronic nose: emerging biomarkers in lung cancer diagnostics 2019 ·Breathe ·Wouter H. van Geffen, Kevin Lamote, Adrien Costantini, Lizza Hendriks, Najib M. Rahman, Torsten Blum, Jan P. van Meerbeeck	16
12	Quantitative Evaluation of Lobar Pulmonary Function of Emphysema Patients with Endobronchial Coils 2019 ·Respiration ·Mali Shen, (unknown), William McNulty, Justin Garner, Hasti Robbie, (unknown), (unknown), Wouter H. van Geffen, Samuel V. Kemp, Carole A. Ridge, Anand Devaraj, Pallav L. Shah, Guang‐Zhong Yang	8
13	Changes in ventilation–perfusion during and after an COPD exacerbation: an assessment using fluid dynamic modeling 2018 ·International Journal of COPD ·Bita Hajian, Jan De Backer, Wim Vos, Wouter H. van Geffen, P D Winter, Omar S. Usmani, Anthony Cahn, Huib A.M. Kerstjens, Massimo Pistolesi, Wilfried De Backer	12
14	Functional respiratory imaging: heterogeneity of acute exacerbations of COPD 2018 ·International Journal of COPD ·Wouter H. van Geffen, Bita Hajian, Wim Vos, Jan De Backer, Anthony Cahn, Omar S. Usmani, Cedric Van Holsbeke, Massimo Pistolesi, Huib A.M. Kerstjens, Wilfried De Backer	10
15	Emerging bronchoscopic treatments for chronic obstructive pulmonary disease 2017 ·Pharmacology & Therapeutics ·Wouter H. van Geffen, Huib A.M. Kerstjens, Dirk‐Jan Slebos	19
16	Diagnosing viral and bacterial respiratory infections in acute COPD exacerbations by an electronic nose: a pilot study 2016 ·Journal of Breath Research ·Wouter H. van Geffen, (unknown), Huib A.M. Kerstjens	54
17	Lung volume reduction for emphysema 2016 ·The Lancet Respiratory Medicine ·Pallav L. Shah, Felix Herth, Wouter H. van Geffen, Gaëtan Deslée, Dirk‐Jan Slebos	88
18	Differential switching to IgG and IgA in active smoking COPD patients and healthy controls 2012 ·European Respiratory Journal ·Corry‐Anke Brandsma, Huib A.M. Kerstjens, Wouter H. van Geffen, Marie Geerlings, Dirkje S. Postma, Machteld N. Hylkema, Wim Timens	36
19	Surviving Respiratory Insufficiency with Intensive Care Support in a Pretreated, Extensively Metastasized Patient with an EML4-ALK Translocation 2012 ·Journal of Thoracic Oncology ·Wouter H. van Geffen, T. Jeroen N. Hiltermann, Harry J.M. Groen	3
20	Increased levels of (class switched) memory B cells in peripheral blood of current smokers 2009 ·Respiratory Research ·Corry‐Anke Brandsma, Machteld N. Hylkema, Marie Geerlings, Wouter H. van Geffen, Dirkje S. Postma, Wim Timens, Huib A.M. Kerstjens	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact